HUIZHOU SHUANGCHENG TECHNOLOGY CO., LTD. – Trademark Portfolio

Entity Type: 16

HUIZHOU SHUANGCHENG TECHNOLOGY CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 7 (Machinery) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include AXIDI. The owner is based in HUIZHOU CITY.

ROOM 101, BLOCK 1, OFFICE BUILDING, NO.

4, YANHU DISTRICT, QIUCHANG BAISHI VILLAGE,, HUIYANG DISTRICT,

HUIZHOU CITY , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AXIDI
AXIDI
Registered 2020

Trademark Classifications

HUIZHOU SHUANGCHENG TECHNOLOGY CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

7
Machinery (1 filing)

Machines and machine tools; motors and engines; machine coupling and transmission components

Frequently Asked Questions

How many trademarks does HUIZHOU SHUANGCHENG TECHNOLOGY CO., LTD. have?

HUIZHOU SHUANGCHENG TECHNOLOGY CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does HUIZHOU SHUANGCHENG TECHNOLOGY CO., LTD. file in?

HUIZHOU SHUANGCHENG TECHNOLOGY CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 7 (Machinery). Class 7 covers machines and machine tools; motors and engines; machine coupling and transmission components.

What are HUIZHOU SHUANGCHENG TECHNOLOGY CO., LTD.'s most well-known trademarks?

HUIZHOU SHUANGCHENG TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as AXIDI. These are among 1 currently registered trademark in the portfolio.

What is HUIZHOU SHUANGCHENG TECHNOLOGY CO., LTD.'s trademark registration success rate?

HUIZHOU SHUANGCHENG TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.